CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,000 | $1,359,000 | 100.00% |
TSP Capital Management Group, LLC | 236,919 | $1,197,000 | 0.67% |
Meditor Group Ltd | 6,312,700 | $1,249,000 | 0.26% |
Anson Funds Management LP | 1,229,844 | $243,000 | 0.14% |
Cresset Asset Management, LLC | 6,865,000 | $1,359,000 | 0.08% |
Telemetry Investments, L.L.C. | 348,501 | $69,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 789,260 | $156,000 | 0.02% |
Benchmark Capital Advisors | 32,600 | $6,000 | 0.01% |
BOENNING & SCATTERGOOD, INC. | 74,950 | $15,000 | 0.01% |
Stratos Wealth Partners, LTD. | 250,000 | $49,000 | 0.00% |